---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-007077"
form_type: "8-K"
ticker: "ACRV"
cik: "0001781174"
company_name: "Acrivon Therapeutics, Inc."
filed_at: "2026-01-08T23:59:59+00:00"
generated_at: "2026-05-16T11:14:33.628817+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Acrivon Therapeutics Provides Clinical Data Updates for ACR-368 and Initial ACR-2316 Data

## Summary
- On January 8, 2026, Acrivon hosted a webcast and conference call featuring ACR-368 clinical data and program updates.
- Initial clinical data for ACR-2316 were presented during the webcast.
- The presentation was posted on the company website at ir.acrivon.com under Investors & Media.
- Exhibit 99.1 to the 8-K filing contains the January 8, 2026 Data Update.

## SEC filing metadata
- accession: 0001193125-26-007077
- form_type: 8-K
- ticker: ACRV
- cik: 0001781174
- company_name: Acrivon Therapeutics, Inc.
- filed_at: 2026-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781174/000119312526007077/0001193125-26-007077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781174/000119312526007077/acrv-20260108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-007077
- JSON: https://secwatch.observer/filing/0001193125-26-007077.json
- Plain text: https://secwatch.observer/filing/0001193125-26-007077.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.